Jaw Keratocysts and Sotos Syndrome
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Download PDF File
Folia Morphol. Vol. 77, No. 2, pp. 386–392 DOI: 10.5603/FM.a2017.0080 O R I G I N A L A R T I C L E Copyright © 2018 Via Medica ISSN 0015–5659 www.fm.viamedica.pl Incidental imaging findings of congenital rib abnormalities: a case series and review of developmental concepts A.M. Aignătoaei1, C.E. Moldoveanu2, I.-D. Căruntu3, S.E. Giuşcă3, S. Partene Vicoleanu3, A.H. Nedelcu3 1Department of Pathology, “Sf. Spiridon” Clinic Hospital, 1, Independenţei Square, Iaşi, Romania 2Department of Radiology, Pneumology Clinic Hospital, 30, dr. Iosif Cihac Street, Iaşi, Romania 3Department of Morphofunctional Sciences, “Grigore T. Popa” University, 16, University Street, Iaşi, Romania [Received: 12 June 2017; Accepted: 24 July 2017] Background: Congenital rib abnormalities are found in approximately 2% of the general population. Usually, they occur in isolation and are rarely symptomatic, but they can also be associated with other malformations. Materials and methods: We reviewed imaging examinations performed over a period of 2 years (2014–2015), enabling us to identify isolated rib abnormalities in 6 adult patients. Results: The case series consisted in 3 cases with bilateral cervical ribs and 1 case each with bifid rib, costal fusion and rib pseudarthrosis. In all patients, the costal anomalies were discovered incidentally. All rib malformations were detected at thoracic radiography, except for the rib pseudarthrosis, which was identified at computed tomography (CT) scan. Differential diagnosis was made between cer- vical ribs and abnormalities of the C7 transverse process and of the first rib, while the other costal malformations were distinguished from tumoural, traumatic or inflammatory lesions of the chest wall, lung and pleura. -
Megalencephaly and Macrocephaly
277 Megalencephaly and Macrocephaly KellenD.Winden,MD,PhD1 Christopher J. Yuskaitis, MD, PhD1 Annapurna Poduri, MD, MPH2 1 Department of Neurology, Boston Children’s Hospital, Boston, Address for correspondence Annapurna Poduri, Epilepsy Genetics Massachusetts Program, Division of Epilepsy and Clinical Electrophysiology, 2 Epilepsy Genetics Program, Division of Epilepsy and Clinical Department of Neurology, Fegan 9, Boston Children’s Hospital, 300 Electrophysiology, Department of Neurology, Boston Children’s Longwood Avenue, Boston, MA 02115 Hospital, Boston, Massachusetts (e-mail: [email protected]). Semin Neurol 2015;35:277–287. Abstract Megalencephaly is a developmental disorder characterized by brain overgrowth secondary to increased size and/or numbers of neurons and glia. These disorders can be divided into metabolic and developmental categories based on their molecular etiologies. Metabolic megalencephalies are mostly caused by genetic defects in cellular metabolism, whereas developmental megalencephalies have recently been shown to be caused by alterations in signaling pathways that regulate neuronal replication, growth, and migration. These disorders often lead to epilepsy, developmental disabilities, and Keywords behavioral problems; specific disorders have associations with overgrowth or abnor- ► megalencephaly malities in other tissues. The molecular underpinnings of many of these disorders are ► hemimegalencephaly now understood, providing insight into how dysregulation of critical pathways leads to ► -
The First Non-Invasive Prenatal Test That Screens for Single-Gene Disorders
The first non-invasive prenatal test that screens for single-gene disorders the evolution of NIPT A non-invasive prenatal test that screens multiple genes for mutations causing severe genetic disorders in the fetus analyses circulating cell- free fetal DNA (cfDNA) from a maternal blood sample. The test is performed after 10 weeks of pregnancy. works as a complementary screen to traditional and genome- wide NIPT . It screens for several life-altering genetic disorders that are not screened with current NIPT technology, allowing a complete picture of the risk of a pregnancy being affected by a genetic disorder. 2 facilitates early diagnosis of single-gene disorders. It involves 3 different levels of screening: This test screens for 5 common inherited recessive genetic disorders, such as Cystic Fibrosis, Beta-Thalassemia, Sickle INHERITED cell anaemia, Deafness autosomal recessive type 1A, Deafness autosomal recessive type 1B. Genes screened: CFTR, CX26 (GJB2), CX30 (GJB6), HBB This test screens for 44 severe genetic disorders due to de novo mutations (a gene mutation that is not inherited) in 25 genes DE NOVO Genes screened: ASXL1, BRAF, CBL, CHD7, COL1A1, COL1A2 , COL2A1, FGFR2, FGFR3, HDAC8, JAG1, KRAS, MAP2K1, MAP2K2, MECP2, NIPBL, NRAS, NSD1, PTPN11, RAF1, RIT1, SETBP1, SHOC2, SIX3, SOS1 This test screens for both inherited and de novo single-gene disorders and represents a combination of the tests INHERITED COMPLETE and DE NOVO providing a complete picture of the pregnancy risk. 3 allows detection of common inherited genetic disorders in INHERITED the fetus GENE GENETIC DISORDER CFTR Cystic Fibrosis CX26 (GJB2) Deafness autosomal recessive type 1A CX30 (GJB6) Deafness autosomal recessive type 1B HBB Beta-Thalassemia HBB Sickle cell anemia The inherited recessive disorders screened by INHERITED are the most common in the European population 4 identifies fetal conditions that could be missed by traditional DE NOVO prenatal screening. -
Modeling Congenital Disease and Inborn Errors of Development in Drosophila Melanogaster Matthew J
© 2016. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2016) 9, 253-269 doi:10.1242/dmm.023564 REVIEW SUBJECT COLLECTION: TRANSLATIONAL IMPACT OF DROSOPHILA Modeling congenital disease and inborn errors of development in Drosophila melanogaster Matthew J. Moulton and Anthea Letsou* ABSTRACT particularly difficult to manage clinically {e.g. CHARGE syndrome Fly models that faithfully recapitulate various aspects of human manifesting coloboma [emboldened words and phrases are defined disease and human health-related biology are being used for in the glossary (see Box 1)], heart defects, choanal atresia, growth research into disease diagnosis and prevention. Established and retardation, genitourinary malformation and ear abnormalities new genetic strategies in Drosophila have yielded numerous (Hsu et al., 2014), and velocardiofacial or Shprinstzens syndrome substantial successes in modeling congenital disorders or inborn manifesting cardiac anomaly, velopharyngeal insufficiency, errors of human development, as well as neurodegenerative disease aberrant calcium metabolism and immune dysfunction (Chinnadurai and cancer. Moreover, although our ability to generate sequence and Goudy, 2012)}. Estimates suggest that the cause of at least 50% of datasets continues to outpace our ability to analyze these datasets, congenital abnormalities remains unknown (Lobo and Zhaurova, the development of high-throughput analysis platforms in Drosophila 2008). It is vital that we understand the etiology of congenital has provided access through the bottleneck in the identification of anomalies because this knowledge provides a foundation for improved disease gene candidates. In this Review, we describe both the diagnostics as well as the design of preventatives and therapeutics that traditional and newer methods that are facilitating the incorporation of can effectively alleviate or abolish the effects of disease. -
Metacarpophalangeal Pattern Profile Analysis in Sotos Syndrome
View metadata, citation and similar papers at core.ac.uk brought to you by CORE HHS Public Access provided by IUPUIScholarWorks Author manuscript Author ManuscriptAuthor Manuscript Author Am J Med Manuscript Author Genet. Author Manuscript Author manuscript; available in PMC 2017 September 12. Published in final edited form as: Am J Med Genet. 1985 April ; 20(4): 625–629. doi:10.1002/ajmg.1320200408. Metacarpophalangeal Pattern Profile Analysis in Sotos Syndrome Merlin G. Butler, Department of Biology, University of Notre Dame and North Central Regional Genetics Center, Memorial Hospital, South Bend, Indiana Department of Medical Genetics, Indiana University School of Medicine F. John Meaney, Department of Medical Genetics, Indiana University School of Medicine Genetic Diseases Section, Indiana State Board of Health, Indianapolis Smita Kittur, Pediatric Genetics Department, Children’s Medical and Surgical Center, Johns Hopkins Hospital, Baltimore Joseph H. Hersh, and Child Evaluation Center, Department of Pediatrics, University of Louisville School of Medicine Lusia Hornstein Cincinnati Center for Developmental Disorders, Children’s Hospital Medical Center Abstract The metacarpophalangeal pattern profile (MCPP) was analyzed on 16 Sotos syndrome patients. A mean Sotos syndrome profile was produced. Correlation studies confirm clinical homogeneity of Sotos syndrome individuals. Discriminant analysis of Sotos syndrome patients and normal individuals produces a function of two MCPP variables and age, which may provide a useful tool for diagnosis. Keywords Sotos syndrome; metacarpophalangeal pattern profile (MCPP); discriminant analysis; correlation studies INTRODUCTION Sotos syndrome, or cerebral gigantism, was first described by Sotos et al [1964]; at least 100 cases were reported subsequently. This syndrome is characterized by large size at birth, large hands and feet, advanced osseous maturation, macrocephaly with prominent forehead and Address reprint requests to Merlin G. -
Diagnostic Utility of Genome-Wide DNA Methylation Analysis in Mendelian Neurodevelopmental Disorders
International Journal of Molecular Sciences Review Diagnostic Utility of Genome-Wide DNA Methylation Analysis in Mendelian Neurodevelopmental Disorders Sadegheh Haghshenas 1,2 , Pratibha Bhai 2, Erfan Aref-Eshghi 3 and Bekim Sadikovic 1,2,4,* 1 Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada; [email protected] 2 Molecular Genetics Laboratory, Molecular Diagnostics Division, London Health Sciences Centre, London, ON N6A 5W9, Canada; [email protected] 3 Division of Genomic Diagnostics, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA; [email protected] 4 Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada * Correspondence: [email protected] Received: 22 November 2020; Accepted: 4 December 2020; Published: 6 December 2020 Abstract: Mendelian neurodevelopmental disorders customarily present with complex and overlapping symptoms, complicating the clinical diagnosis. Individuals with a growing number of the so-called rare disorders exhibit unique, disorder-specific DNA methylation patterns, consequent to the underlying gene defects. Besides providing insights to the pathophysiology and molecular biology of these disorders, we can use these epigenetic patterns as functional biomarkers for the screening and diagnosis of these conditions. This review summarizes our current understanding of DNA methylation episignatures in rare disorders and describes the underlying technology and analytical approaches. We discuss the computational parameters, including statistical and machine learning methods, used for the screening and classification of genetic variants of uncertain clinical significance. Describing the rationale and principles applied to the specific computational models that are used to develop and adapt the DNA methylation episignatures for the diagnosis of rare disorders, we highlight the opportunities and challenges in this emerging branch of diagnostic medicine. -
Medical Genetics and Genomic Medicine in the United States of America
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by George Washington University: Health Sciences Research Commons (HSRC) Himmelfarb Health Sciences Library, The George Washington University Health Sciences Research Commons Pediatrics Faculty Publications Pediatrics 7-1-2017 Medical genetics and genomic medicine in the United States of America. Part 1: history, demographics, legislation, and burden of disease. Carlos R Ferreira George Washington University Debra S Regier George Washington University Donald W Hadley P Suzanne Hart Maximilian Muenke Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_peds_facpubs Part of the Genetics and Genomics Commons APA Citation Ferreira, C., Regier, D., Hadley, D., Hart, P., & Muenke, M. (2017). Medical genetics and genomic medicine in the United States of America. Part 1: history, demographics, legislation, and burden of disease.. Molecular Genetics and Genomic Medicine, 5 (4). http://dx.doi.org/10.1002/mgg3.318 This Journal Article is brought to you for free and open access by the Pediatrics at Health Sciences Research Commons. It has been accepted for inclusion in Pediatrics Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please contact [email protected]. GENETICS AND GENOMIC MEDICINE AROUND THE WORLD Medical genetics and genomic medicine in the United States of America. Part 1: history, demographics, legislation, and burden of disease Carlos R. Ferreira1,2 , Debra S. Regier2, Donald W. Hadley1, P. Suzanne Hart1 & Maximilian Muenke1 1National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 2Rare Disease Institute, Children’s National Health System, Washington, District of Columbia Correspondence Carlos R. -
Part II Thoracic Spine
Open Access Review Article DOI: 10.7759/cureus.8684 Anatomical Variations That Can Lead to Spine Surgery at The Wrong Level: Part II Thoracic Spine Manan Shah 1 , Dia R. Halalmeh 2 , Aubin Sandio 1 , R. Shane Tubbs 3, 4, 5 , Marc D. Moisi 2 1. Neurosurgery, Wayne State University, Detroit Medical Center, Detroit, USA 2. Neurosurgery, Detroit Medical Center, Detroit, USA 3. Neurosurgery and Structural & Cellular Biology, Tulane University School of Medicine, New Orleans, USA 4. Anatomical Sciences, St. George's University, St. George's, GRD 5. Neurosurgery and Ochsner Neuroscience Institute, Ochsner Health System, New Orleans, USA Corresponding author: Dia R. Halalmeh, [email protected] Abstract Spine surgery at the wrong level is a detrimental ordeal for both surgeon and patient, and it falls under the wrong-site surgery sentinel events reporting system. While there are several methods designed to limit the incidence of these events, they continue to occur and can result in significant morbidity for the patient and malpractice lawsuits for the surgeon. In thoracic spine, numerous risk factors influence the development of this misadventure. These include anatomical variations such as transitional vertebrae, rib variants, hemivertebra, and block/fused vertebrae as well as patient characteristics, such as tumors, infections, previous thoracic spine surgery, obesity, and osteoporosis. An extensive literature search of the PubMed database up to 2019 was completed on each of the anatomical entities and their influence on developing thoracic spine surgery at the wrong level, taking into consideration patient’s individual factors. A reliable protocol and effective techniques were described to prevent this error. -
Regional Genetic Consultation Service
Regional Genetic Consultation Service Contract 5889BD01 July 1, 2018 through June 30, 2019 Congenital & Inherited Disorders Division of Health Promotion & Chronic Disease Prevention, Phone: 1-800-383-3826 http://idph.iowa.gov/genetics Regional Genetic Consultation Service: A contract established by IDPH in the Division of Health Promotion & Chronic Disease Prevention, Contract # 5888BD01 Administrative Code, Chapter 4:641-4.5(136A) Iowa Department of Public Health Advancing Health Through the Generations Kimberly Reynolds Adam Gregg Gerd Clabaugh Governor Lt. Governor Director Authorized State Official for this contract: Brenda Dobson, Director, Division of Health Promotion and Chronic Disease Prevention (515) 281-7769 University of Iowa Stead Family Department of Pediatrics (319) 356-2675 Hatem El-Shanti, MD, Division Director John A. Bernat, MD, PhD, Clinical Director Hannah Bombei, MS, CGC, Program Coordinator Page | 2 Congenital & Inherited Disorders Division of Health Promotion & Chronic Disease Prevention, Phone: 800-383-3826 http://idph.iowa.gov/genetics In collaboration with the Iowa Department of Public Health & The Stead Family Department of Pediatrics Division of Medical Genetics & Genomics University of Iowa Stead Family Children’s Hospital & Clinical Outreach Services University of Iowa Hospitals and Clinics Page | 3 What is the Regional Genetic Consultation Service? Iowa Administrative Code 641—4.5(136A) Regional Genetic Consultation Service (RGCS). This program provides comprehensive genetic and genomic services statewide through outreach clinics. 4.5(1) Provision of comprehensive genetic and genomic services. The department shall contract with the Division of Medical Genetics & Genomics within the Stead Family Department of Pediatrics at the University of Iowa to provide genetic and genomic health care and education outreach services for individuals and families within Iowa. -
Nova Scotia Atlee Perinatal Database Coding Manual 8Th Edition (Version 8.0)
Nova Scotia Atlee Perinatal Database Coding Manual 8th Edition (Version 8.0) April 2001 NOVA SCOTIA ATLEE PERINATAL DATABASE CODING MANUAL TABLE OF CONTENTS (A) ROUTINE INFORMATION LISTING OF HOSPITALS .......................1 DELIVERED ADMISSIONS ......................3 UNDELIVERED ADMISSIONS ..................59 POSTPARTUM ADMISSIONS ...................69 NEONATAL ADMISSIONS .................... 79 ANOMALY ADMISSIONS ......................91 ................................................. (B) CLASSIFICATION OF MATERNAL DISEASES AND PROCEDURES (Blue Section) I. Previous Pregnancy Maternal Diseases.............. 01 II. Present Pregnancy Maternal Diseases............... 02 A. Obstetrical ..............................02 B. Non-Obstetrical..........................07 C. Labour Complications .....................15 D. Non-Delivery Procedures ..................16 E. Analgesia During Labour ...................20 F. Anesthesia During Labour/Delivery ..........22 G. Anesthesia for Non-Delivery Procedures ......24 H. Lacerations ..............................25 I. Postpartum Complications..................26 J. Postpartum Infections .....................29 K. Maternal Therapy.........................31 L. Maternal Death or Undelivered Fetal Death....33 M. Infection in Present Pregnancy .............34 N. Complications of Anesthesia................37 O. Antibiotic Therapy........................39 P. Fetal Procedures..........................40 Q. Methods of Induction ......................41 8th Edition, April 2001, V8.0 Table of Contents and -
Abstracts Books 2014
TWENTY-FIFTH EUROPEAN MEETING ON DYSMORPHOLOGY 10 – 12 SEPTEMBER 2014 25th EUROPEAN MEETING ON DYSMORPHOLOGY LE BISCHENBERG WEDNESDAY 10th SEPTEMBER 5 p.m. to 7.30 p.m. Registration 7.30 p.m. to 8.30 p.m. Welcome reception 8.30 p.m. Dinner 9.30 p.m. Unknown THURSDAY 11th SEPTEMBER 8.15 a.m. Opening address 8.30 a.m. to 1.00 p.m. First session 1.00 p.m. Lunch 2.30 p.m. to 7.00 p.m. Second and third sessions 8.00 p.m. Dinner 9.00 p.m. to 11.00 p.m. Unknown FRIDAY 12th SEPTEMBER 8.30 a.m. to 1.00 p.m. Fourth and fifth sessions 1.00 p.m. Lunch 2.30 p.m. to 6.00 p.m. Sixth and seventh sessions 7.30 p.m. Dinner SATURDAY 13th SEPTEMBER Breakfast – Departure Note: This program is tentative and may be modified. WEDNESDAY 10th SEPTEMBER 9.30 UNKNOWN SESSION Chair: FRYNS J.P. H. VAN ESCH Case 1 H. VAN ESCH Case 2 H. JILANI, S. HIZEM, I. REJEB, F. DZIRI AND L. BEN JEMAA Developmental delay, dysmorphic features and hirsutism in a Tunisian girl. Cornelia de Lange syndrome? L. VAN MALDERGEM, C. CABROL, B. LOEYS, M. SALEH, Y. BERNARD, L. CHAMARD AND J. PIARD Megalophthalmos and thoracic great vessels aneurisms E. SCHAEFER AND Y. HERENGER An unknown diagnosis associating facial dysmorphism, developmental delay, posterior urethral valves and severe constipation P. RUMP AND T. VAN ESSEN What’s in the name G. MUBUNGU, A. LUMAKA, K. -
Soonerstart Automatic Qualifying Syndromes and Conditions
SoonerStart Automatic Qualifying Syndromes and Conditions - Appendix O Abetalipoproteinemia Acanthocytosis (see Abetalipoproteinemia) Accutane, Fetal Effects of (see Fetal Retinoid Syndrome) Acidemia, 2-Oxoglutaric Acidemia, Glutaric I Acidemia, Isovaleric Acidemia, Methylmalonic Acidemia, Propionic Aciduria, 3-Methylglutaconic Type II Aciduria, Argininosuccinic Acoustic-Cervico-Oculo Syndrome (see Cervico-Oculo-Acoustic Syndrome) Acrocephalopolysyndactyly Type II Acrocephalosyndactyly Type I Acrodysostosis Acrofacial Dysostosis, Nager Type Adams-Oliver Syndrome (see Limb and Scalp Defects, Adams-Oliver Type) Adrenoleukodystrophy, Neonatal (see Cerebro-Hepato-Renal Syndrome) Aglossia Congenita (see Hypoglossia-Hypodactylia) Aicardi Syndrome AIDS Infection (see Fetal Acquired Immune Deficiency Syndrome) Alaninuria (see Pyruvate Dehydrogenase Deficiency) Albers-Schonberg Disease (see Osteopetrosis, Malignant Recessive) Albinism, Ocular (includes Autosomal Recessive Type) Albinism, Oculocutaneous, Brown Type (Type IV) Albinism, Oculocutaneous, Tyrosinase Negative (Type IA) Albinism, Oculocutaneous, Tyrosinase Positive (Type II) Albinism, Oculocutaneous, Yellow Mutant (Type IB) Albinism-Black Locks-Deafness Albright Hereditary Osteodystrophy (see Parathyroid Hormone Resistance) Alexander Disease Alopecia - Mental Retardation Alpers Disease Alpha 1,4 - Glucosidase Deficiency (see Glycogenosis, Type IIA) Alpha-L-Fucosidase Deficiency (see Fucosidosis) Alport Syndrome (see Nephritis-Deafness, Hereditary Type) Amaurosis (see Blindness) Amaurosis